Intervention | Waiting list | |
Subjects n | 12 | 11 |
Males n (%) | 7 (58) | 4 (38) |
Age yrs | 43±10 | 48±12 |
Duration of symptoms yrs | 9±6 | 12±8 |
FEV1 | ||
L | 2.8±0.7 | 2.6±0.6 |
% pred | 85±20 | 90±12 |
FVC | ||
L | 3.9±0.9 | 3.8±0.8 |
% pred | 99±14 | 108±10 |
Prescribed medication | ||
Inhaled β2‐agonists puffs·day−1 | 4.7±4.2 | 4.1±3.0 |
Inhaled steroids µg·day−1 | 1354±607 | 1059±424 |
Theophyllines n | 5 | 2 |
Cromoglycate n | 2 | 4 |
Oral steroids n | 1 | 2 |
Anticholinergics n | 0 | 4# |
Asthma severity n | ||
Mild | 4 | 3 |
Moderate | 7 | 8 |
Severe | 1 | 0 |
Data are presented as mean±sd, unless otherwise stated
FEV1: forced expiratory volume in one second
FVC: forced vital capacity
#: significant difference between both groups